INTRODUCTION {#S1}
============

Neural tissues differentiated from human pluripotent stem cells (hPSCs) have been utilized to probe early human embryonic brain development. Early studies used human embryonic stem cell (hESC)-derived embryoid bodies (EBs) to generate neural precursors, which were isolated, expanded, and directed to neurons, astrocytes (ASs), and oligodendrocytes (OLs) ([@R40]). Further refinement led to the efficient production of neural progenitors by dual SMAD inhibition (transforming growth factor β \[TGFβ\] and bone morphogenetic protein \[BMP\] signaling pathways) under two-dimensional (2D) conditions ([@R7]; [@R10]; [@R16]). Although the utility of pure neuronal populations produced in 2D has a number of useful applications, such as disease modeling, they do not recapitulate key features of brain physiology. This has led the field to develop advanced three-dimensional (3D) *in vitro* structures that recapitulate the environment of the developing brain, so-called brain organoids (human cortical organoids \[hCOs\]; cortical spheroids) ([@R18]; [@R20]).

The majority of protocols used to produce brain organoids are comprised of three common steps: (1) induction, (2) differentiation, and (3) maturation ([Figure 1](#F1){ref-type="fig"}). In brief, for induction, EBs are produced and directed toward a cortical neuroectoderm fate with or without chemical inhibitors for up to 18 days in serum-free suspension culture. After the neuroectodermal induction, brain organoids are cultured in the differentiation medium containing supplements (e.g., N2 or B27), providing ideal conditions for cell survival and developmental progression to neuron and glial cells. To support morphogenesis and nutrient absorption, extracellular-matrix-based hydrogels and rotational bioreactors are applied during neuronal differentiation ([@R21]). Once patterned into a specific brain region, the organoids are matured in medium supplemented with retinoic acid and maintained long term.

Recent advances in the brain organoid field have led to the development of protocols that allow efficient and rapid formation of brain organoids. These methods devised by multiple laboratories are broadly classified into either a guided or non-guided approach with regard to neuroectoderm initiation/commitment ([Table 1](#T1){ref-type="table"}). Sasai and colleagues established the first guided protocol by using a combination of inhibitors of the WNT, BMP, and TGFβ pathways, driving a rostral-dorsal pallial fate upon neuronal induction ([@R9]). Another study used inhibition of the sonic hedgehog (SHH) pathway to direct the formation of dorsal cortical organoids ([@R12]). For robust survival of neuronal progenitors, the above Sasai method was further modified by incorporating lipid concentrate, serum, heparin, and Matrigel, which facilitated the robust survival of neuronal progenitors ([@R17]). Another study using this protocol showed the production of organoids exhibiting low variability in structure and gene expression ([@R34]). To improve cortical lamination and functional synaptogenesis, the Pasca group used growth factors either during neuronal differentiation (FGF2 and EGF) or maturation (BDNF \[brain-derived neurotrophic factor\] and NT-3 \[neurotrophin-3\]), which supported lineage commitment and morphogenesis of organoids ([@R3]; [@R27]). This method was also used to generate OL-containing cortical organoids ([@R26]) and establish oscillatory networks in these organoids under long-term culture with additional nutrients (e.g., cyclic AMP \[cAMP\] and vitamin C) ([@R33]). [@R36] used a guided approach to generate dorsal forebrain using a cocktail of WNT, BMP, and TGFβ inhibitors without Matrigel. The Knoblich group pioneered a non-guided method of brain organoid generation using the intrinsic property of hPSCs to differentiate toward the neuroectodermal lineage under serum-free conditions ([@R21]). The non-guided organoids did not display a specific regional identity but broadly contained clusters of cells representing the regions of a diverse rostral forebrain. Large-scale single-cell transcriptional sequencing revealed cellular diversity, maturity, and spontaneous neural networks in non-guided brain organoids ([@R30]). Recent complementation with air-liquid interface culture methods improved neuronal survival and outgrowth in non-guided brain organoids ([@R13]).

Each study on brain organoids reported the comprehensive analysis of structure and function, including an analysis of cellular composition. However, no studies have yet evaluated how different methods gave rise to distinctive features in the brain organoids, which will be essential to determine the appropriate method for a specific purpose. Here, we have composited single-cell RNA sequencing (scRNA-seq) datasets from brain organoids generated by different approaches and dissected the state and heterogeneity of individual cells within these organoid models.

RESULTS {#S2}
=======

Organoids Derived from a Non-guided Protocol Possess a More Divergent Cell Composition {#S3}
--------------------------------------------------------------------------------------

Microdroplet-based single-cell transcriptome profiles of cortical organoids from eight different protocols were collected from public resources ([Table 1](#T1){ref-type="table"}; [@R3]; [@R12]; [@R13]; [@R26]; [@R30]; [@R33]; [@R34]; [@R36]). scRNA-seq from the developing human prefrontal cortex in gestational weeks 8 to 26 was added as a *in vivo* benchmark ([@R41]). After filtering out the cells by quality control, a total of 190,022 cells were projected into an adjusted 2D space by Uniform Manifold Approximation and Projection (UMAP). All cells were classified into 24 distinct clusters ([Figure S1A](#SD1){ref-type="supplementary-material"}) and systematically labeled as 13 cell types based on the following combined parameters, including expression patterns of cell-type-specific gene signatures ([@R8]), Gene Ontology (GO) annotation, amino acid neurotransmitter transporters, and several unique markers ([@R37]; [Figures 2A](#F2){ref-type="fig"}, [S1B](#SD1){ref-type="supplementary-material"}, and [S1C](#SD1){ref-type="supplementary-material"}; see [STAR Methods](#S8){ref-type="sec"}). We also implemented the web-based interface together with University of California Santa Cruz (UCSC) Cell Browser and provided a powerful interactive tool to explore all the composited scRNA-seq datasets (<https://cells-test.gi.ucsc.edu/?ds=organoidatlas>) that provide the identity of cell clusters, reference genes for each cluster, composition of each datasets, and aging of organoids among other important information. Overall, these diverse protocols produced brain organoids that exhibit similar cell repertoires, except for a few cell types ([Figures 2B](#F2){ref-type="fig"} and [2C](#F2){ref-type="fig"}). In all cases, cortical neuron (CN), immature neuron (Neuron), neuroepithelial cell (NEC), and AS clusters were identified. A cluster of mesodermal cells (MEs) was identified in the Quadrato dataset ([@R30]). This is probably due to the non-guided and prolonged culture condition. Although endothelium and microglia cell are derived from the mesoderm, no substantial expression of these markers were detected in the majority of organoids, including the Quadrato study ([Figure S1D](#SD1){ref-type="supplementary-material"}). Cell clusters represented by cilium (cilia-bearing cell \[CBC\]) and BMP signaling (BMP-related cell \[BRC\]), which are crucial for early neurogenesis and survival ([@R14]), were observed both in fetal brain and in all hCOs ([Figure 2D](#F2){ref-type="fig"}). In the developing early brain, OLs originate in the ventral brain and migrate to the dorsal cortex ([@R19]). Because the dorsal origin of OLs arises at the postnatal stage, mature OL markers are absent in most of the region-specific brain organoids ([Figure S1E](#SD1){ref-type="supplementary-material"}). OLs cluster with the myelination factors (APOD and CSPG4) and were only identified in Quadrato's non-guided organoids after long-term culture and in the fetal cortex where OL precursors have already migrated from the ventral side and matured ([Figure S1E](#SD1){ref-type="supplementary-material"}). ME or OL clusters were not detected in early stage non-guided organoid described by [@R13], implying that these cell types arose at a later stage of development.

In addition to the well-defined cell populations, previously uncharacterized cell types were identified in this unbiased analysis of scRNA-seq transcriptomes. In one of our previous studies, we identified clusters of cells that were different from both neurons and astrocytes but expressed genes for proteoglycan (\[PGC\] proteoglycan cluster) ([@R37]; [Figure 2D](#F2){ref-type="fig"}). We also found that PGCs were detectable in the human fetal cortex and indeed most of the hCOs datasets ([Figure 2C](#F2){ref-type="fig"}). In particular, the long-term organoids from the Quadrato study produced a large number of cells categorized to the PGC clusters. The PGC clusters also highly expressed endothelial gene signatures, although none of the organoid systems reported here had any evidence of a vascular system, which was confirmed also by the lack of induction of the transcription factor ETV2, which facilitates endothelial commitment ([Figures 2E](#F2){ref-type="fig"} and [S1D](#SD1){ref-type="supplementary-material"}; [@R5]). PGCs, however, do not express any vasculogenesis markers ([Figure S1C](#SD1){ref-type="supplementary-material"}), suggesting that PGCs are potentially clusters of precursor cells for the endothelial lineage ([@R35]).

Developing human fetal brains display progressive change in transcription at different time points ([@R41]). Likewise, developing brain organoids are expected to represent a certain developmental stage. We asked at which developing brain stage the given organoids represent and whether the different protocols used affect the developmental stage of the organoid. To estimate the developmental stage of the respective organoids, we compared the expression of the stage-specific genes obtained from fetal brains at 8 to 37 post-conceptual week (pcw) with those from each organoid scRNA-seq dataset. We then assigned the brain stage to the respective brain organoids with the highest enrichment of gene signatures corresponding to the "age." Albeit the diversity in protocols, a significant correlation between organoid age and time point of fetal brain could be assigned ([Figure 2F](#F2){ref-type="fig"}).

Together, these results suggest that hCOs generated from different protocols produce similar cell types and non-guided methods give rise to organoids with more heterogeneous cell compositions than those made by guided methods. Additionally, unbiased analysis in scRNA-seq revealed the presence of unique cell types derived from brain organoids.

Developmental Bypasses for Brain Development {#S4}
--------------------------------------------

Although similar cell clusters were found in hCOs developed from different protocols ([Figure 2A](#F2){ref-type="fig"}), neuroectoderm commitment by different inhibitors in guided or non-guided differentiation are likely to follow different routes. To investigate this, we analyzed the dynamic process of cell fate transition and determined the differentiation trajectory during brain organoid development among the different protocols ([Figure 3A](#F3){ref-type="fig"}; [@R23]). Pseudo-temporal modeling ordered cells from proliferative NECs to post-mitotic neuron and glia ([Figure S2A](#SD1){ref-type="supplementary-material"}; [@R6]). The reconstructed trajectory revealed the existence of multiple developmental bypasses (B1, B2, and B3) at the early stage of development ([Figures 3B](#F3){ref-type="fig"} and [S2B](#SD1){ref-type="supplementary-material"}). Because the majority of NECs passed B1 bypass in all protocols, B1 is interpreted as the major neuronal differentiation route. One of the alternative routes, B2, also contains many mitotic NECs, and the minor alternative route B3 is mainly composed of CBCs and BRCs. Surprisingly, organoids from each protocol displayed a difference in selecting these bypasses ([Figure 3C](#F3){ref-type="fig"}). The Sasai-based methods from [@R12] and [@R34] showed the highest preference (\>25%) for the B2 bypass but also produced a limited number of cells in B3. In contrast, our protocol ([@R36]) and the non-guided approach of [@R30] preferentially generated cells passing through the B3 bypass. To characterize transcriptional features among these developmental bypasses, we analyzed the dynamics of gene regulation in each bypass. Cells in B1 induced several replication genes related to the proliferation of neuronal stem cells (e.g., GINS2 and CDT1) and transcription factors controlling early neurogenesis and self-renewal (e.g., HELLS) ([Figure 3D](#F3){ref-type="fig"}). In B2 bypass, cell cycle regulators (e.g., CCNB1 and CDC20) were preferentially expressed. The expression of genes for insulin response (e.g., IGFBP7 and TTR) were found in the B3 bypass that may be induced by insulin contained in the medium ([Table 1](#T1){ref-type="table"}). Our results underline that alternative differentiation routes that may exist during brain development can be selectively induced during organoid formation.

Transcriptional Biases in Organoid Protocols {#S5}
--------------------------------------------

Next, we addressed whether specific biological processes are induced by different organoid protocols. scRNA-seq data from each organoid was compared with its corresponding developmental brain stage ([Figure 2F](#F2){ref-type="fig"}). A small number of genes (approximately 10--100 genes) were differentially regulated for brain organoids derived from each protocol ([Figure 3E](#F3){ref-type="fig"}). All organoid protocols showed a significant upregulation of genes related to either focal adhesion or endoplasmic reticulum (ER) that regulates protein trafficking in dendritic spines ([@R31]). In addition, a significant downregulation of aerobic respiration and an upregulation of apoptotic genes were observed in the organoids ([Figure 3F](#F3){ref-type="fig"}). This observation may be a result of the limited exchange of oxygen and nutrient into the innermost regions of the organoids, given the lack of vascular structures in the system. This is also consistent with the previous findings that organoid models preferentially express glycolysis-related genes ([@R29]). In terms of the utility of hCOs in modeling neuropsychiatric or other related diseases, we investigated whether the respective organoid systems have evidence of enrichment of disease-related genes. The majority of the protocols reported thus far did not display an inclination of gene expression involved in the given disorders ([Figure 3G](#F3){ref-type="fig"}). Taken together, we conclude that current hCO systems are applicable for disease modeling or drug screening without concerns in the transcriptional biases toward specific disease-related genes.

Developmental Origin of Interneurons {#S6}
------------------------------------

In the rodent, GABAergic interneurons (INs) mainly emerge from the sub-pallial medial ganglionic eminences (MGEs) and caudal ganglionic eminence (CGE) ([@R4]). The majority of INs in primates are known to arise at the sub-pallial ventral cortex, whereas the dorsal forebrain origin of INs is an outstanding topic yet to be resolved. The field has become mired with a number of seemingly contradictory reports and these include the following: (1) more than half of the INs originate from the neocortical ventricular and subventricular zone of the dorsal cortex ([@R22]), (2) human INs are primarily emigrants from the GE but also arise from dorsal cortex at a later stage ([@R39]), and (3) the vast majority of INs are derived from the GE ([@R15]; [@R24]). In all cases, these conclusions were supported by immunohistochemistry against IN markers and retroviral labeling/tracing of INs in human fetal brain slices. However, there was no definitive proof for a ventral cortical origin for INs. Using fusion organoid models, we and others demonstrated that GABAergic INs arose from the MGE/sub-pallium and migrated into the cortex of hCOs, thus reproducing the tangential migration of INs in the developing cortex ([@R2]; [@R3]; [@R36]). Surprisingly, we noted that the hCOs generated without SHH agonists produced a substantial number of GABAergic INs that were distinct from INs of a MGE origin in that they did not express the canonical ventral ganglionic marker NKX2--1 ([@R36], [@R37]). Here, we addressed whether hCOs generated from other protocols contained INs. Regardless of the method of neuroectodermal initiation, guided or non-guided, or whether chemicals or cytokines were used, the majority of hCOs produced a significant number of the INs with the exception of the [@R3] protocol ([Figure 3H](#F3){ref-type="fig"}). None of hCOs displayed a ventral forebrain identity with no or negligible level of NKX2--1 expression detectable ([Figure 3I](#F3){ref-type="fig"}). To address the Birey study and the lack of INs, which in part may have been a consequence of a small organoid sample size with repect to the limited scRNA-seq read counts, we further examined the presence of INs in the Birey organoids by bulk RNA-seq, which included data from both young and old brain organoids ([@R38]). The GABAergic transporters (e.g., vGAT) were not detected at the early time point of their cortical organoids (\<day 25), but these markers were highly expressed in older organoids (\>day 50) ([Figure S2C](#SD1){ref-type="supplementary-material"}). Overall, the majority of hCO systems published so far appear to support the dorsal cortical origin of inter-neurogenesis. However, future research will be required to support these conclusions.

DISCUSSION {#S7}
==========

With the rapid advancement of single-cell-based technologies, enormous amounts of single-cell transcriptome datasets are readily accessible from the public domain, including scRNA-seq data from brain organoids. Our integrative analyses of the single-cell transcriptome of hCOs illustrated how the multiple "artificial' culture systems remarkably reproduced both the developmental aspects and production of "*de facto*" brain tissue and defined the characteristics unique to brain organoids generated from each protocol. Our evaluation focused on transcriptional features of individual cells in the organoid. In future studies, combining the cell distribution and morphology, electrophysiological activities inside of organoids, and connectivity will be essential to assess functional aspects of brain organoids to understand human cortical development and to model brain diseases.

STAR★METHODS {#S8}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S9}
---------------------------------------

Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Dr. In-Hyun Park (<inhyun.park@yale.edu>). This study did not generate new unique reagents.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S10}
--------------------------------------

In this work, we studied single-cell transcriptome profiles of brain organoids, which were produced by different laboratories. The ages of the organoids are from one week up to six months.

METHOD DETAILS {#S11}
--------------

### Data Collection {#S12}

The scRNA-seq datasets derived from microdroplet platforms were retrieved and collected from NCBI Short Read Archive. For 10x Genomics platform, either SRA or BAM-formatted files were downloaded and converted into fastq files by fastq-dump (v2.9.4) or bamtofastq (v1.1.2), respectively. Raw sequence files were mapped to the hg19 human genome and the latest Ensembl gene annotation by count function of CellRanger with default parameters (v2.1.0). Multiple sequencing runs from the same study were pooled using aggr function of CellRanger. For the other platforms of single-cell transcriptomes, gene-cell count matrices were obtained from NCBI Gene Expression Omnibus (GEO). We used PGP1 scRNA-seq datasets from [@R34] because PGP1 datasets include multiple batch replicates. Single-cell transcriptome profile from human fetal cortex was also obtained from NCBI GEO ([@R41]). The count matrix table from bulk RNA-seq of hCOs by [@R3] method (GSE120700) was downloaded from the NCBI GEO database ([@R38]).

### Preprocessing of scRNA-seq {#S13}

All scRNA-seq libraries from hCOs and human fetal brains were integrated by Seurat (v3.0) under R (v3.5.0) environment. Briefly, as quality control, we removed cells, including less than 1,000 detected genes and genes expressed in less than 5 cells. For each organoid study, the feature counts were normalized to the total counts and multiplied by 10,000 scaling factor. Highly-variable features (genes) were then selected by Variance Stabilizing Transformation (VST). After prioritizing features by their variance across scRNA-seq libraries, top 2,000 features were retained for downstream analysis. Cell pairwise anchor correspondences between different single-cell transcriptome studies were identified with 30-dimensional spaces from canonical correlation analysis (CCA). Using these anchors, scRNA-seq datasets were integrated and transformed into a shared space. Gene expression values were scaled for each gene across all integrated cells and used for principal component analysis (PCA). Using 1^st^ to 30^th^ principal components (PCs), all cells were assigned into two-dimensional UMAP space. Cell clusters were identified with 1^st^ to 30^th^ PCs. Differentially-expressed genes in each cluster were identified with more than 1.25 average fold change and p \< 0.05 by two-sided t test. Overrepresented GO terms were identified by GOstats (v2.24.0) ([@R11]). False discovery rate (FDR) was estimated by Benjamini-Hochberg method with p.adjust function. FDR \< 0.05 was defined as statistical significance.

### Defining and Assigning Cell Types for Individual Cells {#S14}

Cell types were assigned to the clusters as described previously with small modifications ([@R36], [@R37]). Briefly, the clusters were first separated by general neuronal markers (STMN2, GAP43, and DCX) and early neurogenesis genes (VIM, HES1, and SOX2) into two main groups: neuronal and non-neuronal group ([Figure S1B](#SD1){ref-type="supplementary-material"}). The neuronal group was further classified into the cortical neuron (CN) and interneuron (IN) according to the expression of cortical neuronal marker (TBR1) and amino acid synthetic enzymes and transporters (GAD1, GAD2, vGLUT1, and vGAT). Neuronal clusters without these specific genes were annotated as an immature neuron.

As shown previously ([@R37]), human brain organoid and fetal brain include indeterminate cell types expressing biglycan and decorin. We allocated two clusters with high expression of these proteoglycans as the proteoglycan-expressing cell (PGC). Two clusters were annotated as a cilium-bearing cell (CBC) and BMP responsible cell (BRC) with the enrichment of genes related to "Cilium assembly (GO:0044458)" and "Response to BMP (GO:0030509)," respectively. Two non-neuronal clusters display the enrichment of genes related to "endoplasmic reticulum unfolded protein response (GO:0030968)." Four mitotic cell clusters were identified by high expression of cell cycle-related genes and assigned as proliferative neuroepithelial cell (NEC). A mesodermal cell cluster was identified with myosin (MYL1 and MYH3) and "myofibril (GO:0030016)" genes.

Five clusters showing a significant overrepresentation of "Glia cell differentiation (GO:0010001)" were categorized as glial cells and further annotated as oligodendrocyte (OL), and astrocyte (AS) by unique markers for each cell type (OLIG1/2, GFAP, SLC1A4 and S100B) and a GO term "Astrocyte differentiation (GO:0048708)." One glia cluster lacking these markers was labeled as glial progenitor cell (GPC). The rest cluster was labeled as intermediate. This annotation scheme was also drawn in [Figure S1B](#SD1){ref-type="supplementary-material"}.

The cell type annotation was verified in individual cells by gene signatures of the neuron, NEC, astrocyte, oligodendrocyte, microglia and endothelial cells, which were obtained as described previously ([@R36]) from single-cell transcriptome in human fetal and adult brains ([@R8]) ([Figure S1D](#SD1){ref-type="supplementary-material"}). In each cell, genes are pre-ranked by relative expression to the average of all cells. The enrichment of the gene signature was evaluated by GSEAPY software (v0.9.3) with "--max-size 50000--min-size 0 -n 1000" options.

Glutamatergic and GABAergic neurons were defined by expression of their transporter genes (SLC17A7, SLC17A6, and SLC32A1).

### Correlation analysis of organoid age with fetal brain stage {#S15}

Transcriptome patterns in developing fetal brains (8, 9, 12, 13, 16, 17, 19, 21, 24 and 37 pcw) were downloaded from BrainSpan database (<http://www.brainspan.org/>). Differentially-expressed genes with 2 fold change and p \< 0.05 with two-sided t test were defined as gene signatures of each developmental stage of brain. Subsequently, the enrichment of stage-specific gene signatures was evaluated by GSEA (v2.2.2) ([@R32]) with 1,000 permutations. For each single-cell RNA-seq in organoid, genes were preranked by relative expression to average of all single-cell RNA-seq datasets. The fetal brain stage with the most significant enrichment of its gene signature (FDR \< 0.05) was determined as the corresponding stage of each brain organoid. Non-linear regression curve was drawn by Microsoft Excel.

### Differentiation Trajectory Estimation of hCOs {#S16}

Differentiation path of cells in hCOs was traced by shared-nearest-neighbors (SNN) graph based on PCA from Seurat analysis described above. SNN was constructed by buildSNNGraph function with default parameter in the scran Bionconductor package ([@R23]) and visualized with a force-directed algorithm. To draw the backbone of the differentiation trajectory, we used a graph embedding algorithm in Monocle (v2.99.3) package ([@R6]). Briefly, a monocle object was constructed from the UMI count matrix and preprocessed according to its instruction. We replaced data in "normalized_data_projection" and "reduced-DimW" slot with PCA and transposed PCA matrix, respectively. Transposed graph layout matrix was also replaced with data in "reducedDimS," "reducedDimA" and "reducedDimK." The principal graph was learned by learnGraph function with "RGE_method = 'SimplePPT', close_loop=T, prune_graph=T, euclidean_distance_ratio=5, geodestic_distance_ratio=0.1, minimal_branch_len = 0.1" options. Finally, pseudotime was calculated by selecting NEC1 cluster, which displays the highest expression of cell cycle genes, as a root node. Cells were then clustered by Louvain algorithm with "k=15" option and manually grouped according to the developmental bypass.

Genes with differential expression among bypasses were identified by \> 1.25 fold and two-sided t test p value \< 0.05.

### Transcriptional comparison between organoid and fetal brain {#S17}

For the analysis of transcriptional biases, we used the oldest organoid datasets in each study and compared them with the corresponding stage of fetal brain data. Differentially-expressed genes (DEGs) in each organoid method and human fetal brain were identified with \> 1.5-fold change and p \< 0.05 by two-sided t test. In each organoid experiment, unique DEGs were isolated and used for GO analysis. Potential disease-related genes were downloaded from DisGeNET database ([@R28]). Genes with more than 0.25 confidence score were used for GSEA as described above. −log10(FDR) was used for evaluation of transcriptional bias of disease-associated genes.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S18}
---------------------------------------

Statistical details and software used for various types of data analyses in this work are cited in the appropriate sections in the [STAR Methods](#S8){ref-type="sec"}. Briefly, I used rowttests() function for two-sided t test in the identification of differentially-expressed genes, p.adjust() for the multiple test correction, cor.test() for the calculation of Pearson correlation and the corresponding p value and hyperGTest() for the hypergeometic test in GO analysis in R software. Permutation test was performed in Gene Set Enrichment Analysis with GSEA software.

DATA AND CODE AVAILABILITY {#S19}
--------------------------

The raw UMI count matrix combining all described single-cell transcriptome profiles is available at our Mendeley repository (<https://data.mendeley.com/datasets/3wrtkk4w5v/1>). OrganoidAtlas (<https://cells-test.gi.ucsc.edu/?ds=organoidatlas>) is available as an interactive web application to explore the composited scRNA-seq datasets. The accession numbers of public datasets used in this study are listed in [Key Resources Table](#T2){ref-type="table"}.
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![Schematic View of the Culture System Generating hCOs\
Guided protocols are originated from [@R9], while non-guided protocols are from [@R21]. Timeline of neural induction, differentiation, and maturation step is shown across protocols.](nihms-1560133-f0002){#F1}

![Comparative Analyses of Cell Compositions among Different hCO Protocols\
(A and B) UMAP plot of 190,022 single cells distinguished by cell types (A) and protocols (B). AS, astrocyte; BRC, BMP-related cell; CBC, ciliabearing cell; CN, cortical excitatory neuron; GPC, glia progenitor cell; IN, interneuron; ME, mesodermal cell; NEC, neuroepithelial cell; OL, oligodendrocyte; PGC, proteoglycan-expressing cell; RGC, radial glia cell; UPRC, unfolded-protein-response-related cell.\
(C) The presence of cell types in each organoid protocol and human fetal brain. Cell types with \>0.25% of cells are denoted with a plus sign F, [@R12]; V, [@R34]; B, [@R3]; M, [@R26]; T, [@R33]; X, [@R36]; Q, [@R30]; G, [@R13].\
(D) UMAP-based heatmap showing representative genes of cilium, BMP signal, and proteoglycan.\
(E) Gene set enrichment analysis (GSEA) of gene signatures for neuron, replicating NPC, astrocyte, oligodendrocyte, endothelial cell, and microglia. The enrichment and depletion (−log10(FDR)) are scaled with red and blue color, respectively.\
(F) Comparison of organoid ages and brain developing stage. Dots represent scRNA-seq datasets. Color scheme for protocols corresponds to Figure 2B. Pearson correlation coefficient and its statistical significance are also shown.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1560133-f0003){#F2}

![Comparative Analyses of Developmental Paths and Transcriptional Biases among Different Protocols\
(A--C) SNN graph visualization for differentiation trajectory.\
(A) Color scheme for cell types corresponds to that in [Figure 2A](#F2){ref-type="fig"}. Differentiation directions (arrows) were determined by pseudotime in [Figure S2A](#SD1){ref-type="supplementary-material"}.\
(B) Estimated trajectory backbone from the SNN graph.\
(C) Comparison of differentiation trajectory among different protocols.\
(D) SNN-graph-based heatmap showing the expression of representative genes in each bypass.\
(E) The number and characteristics of differentially expressed genes in each organoid protocol. The analysis was performed with the oldest organoid in each protocol.\
(F) GSEA of Gene Ontology (GO) terms between *in vivo* fetal brain and *in vitro* organoid.\
(G) Enrichment of disease-related genes in each organoid.\
(H) The ratio of excitatory and inhibitory neurons among different protocols.\
(I) Comparison of regional identify with NKX2--1 expression among the dorsal and ventral brain organoid. scRNA-seq datasets for the ventral organoid were obtained from [@R3] and [@R36].\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1560133-f0004){#F3}

###### 

Comparison of Medium Compositions and Single-Cell Transcriptome Libraries across Different Protocols

  Components                   [@R12]           [@R34]                   [@R3]            [@R26]                                                     [@R33]                   [@R36]                        [@R30]                        [@R13]
  ---------------------------- ---------------- ------------------------ ---------------- ---------------------------------------------------------- ------------------------ ----------------------------- ----------------------------- ------------------------------------------------------------------
  Induction                                                                                                                                                                                                                               
  Basal medium                 DMEM-F12         Glasgow-MEM              DMEM-F12         DMEM-F12                                                   Neurobasal               DMEM-F12                      DMEM-F12                      DMEM-F12
  Supplement                   KSR              KSR                      KSR              KSR                                                        Gem21 NeuroPlex          KSR                           KSR + N2                      KSR + N2
  β-Me                         O                O                        O                O                                                                                   O                                                           
  TGFβ inh.                    O                O                        O                O                                                          O                        O                                                           
  BMP inh.                     O                                         O                O                                                          O                        O                                                           
  WNT inh.                     O                O                                                                                                                             O                                                           
  SHH inhi.                    O                                                                                                                                                                                                          
  Differentiation                                                                                                                                                                                                                         
  Basal medium                 Neurobasal       DMEM-F12                 Neurobasal       Neurobasal                                                 Neurobasal               DMEM-F12 + Neurobasal (1:1)   DMEM-F12 + Neurobasal (1:1)   DMEM-F12 + Neurobasal (1:1)
  Supplement                   N2               N2 + LC                  B27 (−A)         B27 (−A)                                                   Gem21 NeuroPlex + NEAA   N2 + B27 (−A) + NEAA          N2 + B27 (−A) + NEAA          N2 + B27 (−A) + NEAA
  β-Me                                                                                                                                                                        O                             O                             O
  Insulin                                                                                                                                                                     O                             O                             O
  SHH inh.                     O                                                                                                                                                                                                          
  Growth factor                                                          FGF2/EGF         FGF2/EGF                                                   FGF2                                                                                 
  Matrigel                                                                                                                                                                                                  Yes                           Yes
  Maturation                                                                                                                                                                                                                              
  Basal medium                 Neurobasal       DMEM-F12                 Neurobasal       Neurobasal                                                 Neurobasal               DMEM-F12 + Neurobasal (1:1)   DMEM-F12 + Neurobasal (1:1)   DMEM-F12 + Neurobasal (1:1)
  Supplement                   N2               N2 + FBS+ LC+ B27 (+A)   B27 (+A)         B27 (+A)                                                   Gem21 NeuroPlex + NEAA   N2 + B27 (+A) + NEAA          N2 + B27 (+A) + NEAA          N2 + B27 (+A) + NEAA
  β-Me                                                                                                                                                                        O                             O                             O
  Insulin                                                                                                                                                                     O                             O                             O
  Growth factor                                                          BDNF, NT-3       BDNF, NT-3                                                 BDNF. GDNF. NT-3         BDNF                          BDNF                          
  Matrigel                                      Yes                                                                                                                                                         Yes                           Yes
  Others                                                                                  PDGF-AA, IGF-1, T3, Ketoconazole, Clemastine, GSK2656157   cAMP + Ascorbic acid     cAMP + Ascorbic acid                                        Ascorbic acid + HEPES + Sodium bicarbonate, air-liquid interface
  Single-cell RNA sequencing                                                                                                                                                                                                              
  SRA ID                       SRA: SRP121791   SRA: SRP191528           SRA: SRP096997   SRA: SRP131980                                             SRA: SRP139859           SRA: SRP105219                SRA: SRP083140                SRA: SRP174405
  Age                          \~5 weeks        \~6 months               105 days         10 weeks                                                   6 months                 \~79 days                     \~6 months                    75 days
  Cell count                   13,747           81,524                   4,953            3,743                                                      3,295                    23,707                        43,706                        13,009

PDGF, platelet-derived growth factor; KSR, KnockOut™ Serum Replacement; β-Me, β-mercaptoethanol; Inh., inhibitor; SRA ID, short read archive ID; N2, N-2 Supplement; LC, liquid concentrate; B27, B-27™ supplement; NT-3, neurotrophin-3; PDGF-AA, platelet-derived growth factor-AA; T3, triiodothyronine; NEAA, non-essential amino acid; BDNF, brain-derived neurotrophic factor; GDNF, glial cell line-derived neurotrophic factor; +A, with vitamine A; −A, without vitamine A.

  REAGENT or RESOURCE                                   SOURCE         IDENTIFIER
  ----------------------------------------------------- -------------- --------------------------------------------------------------------------------------------------------------------------
  Deposited Data                                                       
  scRNA-seq for hCOs                                    [@R12]         SRA: SRP121791
  scRNA-seq for hCOs                                    [@R29]         SRA: SRP180337
  scRNA-seq for hCOs                                    [@R34]         SRA: SRP191528
  scRNA-seq for hCOs                                    [@R3]          SRA: SRP096997
  scRNA-seq for hCOs                                    [@R26]         SRA: SRP131980
  scRNA-seq for hCOs                                    [@R33]         SRA: SRP139859
  scRNA-seq for hCOs                                    [@R36]         SRA: SRP105219
  scRNA-seq for hCOs                                    [@R30]         SRA: SRP083140
  scRNA-seq for hCOs                                    [@R13]         SRA: SRP174405
  scRNA-seq for human fetal brains                      [@R41]         GSE: GSE104276
  scRNA-seq for human fetal and adult brains            [@R8]          SRA: SRP057196
  RNA-seq for *in vivo* fetal brain                     BrainSpan      <http://www.brainspan.org/>
  Time-course bulk RNA-seq for hCOs by [@R3] protocol   [@R38]         GSE: GSE120700
  Software and Algorithms                                              
  Bamtofastq (v1.1.2)                                   10x Genomics   <https://support.10xgenomics.com/docs/bamtofastq>
  fastq-dump (v2.9.4)                                   NCBI           <https://github.com/ncbi/sra-tools>
  CellRanger (v2.1.0)                                   10x Genomics   <https://support.10xgenomics.com/single-ceN-gene-expression/software/downloads/latest>
  R (v3.5.0)                                            N/A            <https://www.r-project.org/>
  Seurat (v3.0)                                         [@R25]         <https://satijalab.org/seurat/>
  Monocle (v2.99.3)                                     [@R6]          [http://cole-trapneN-lab.github.io/monocle-release/monode3/](http://cole-trapnen-lab.github.io/monocle-release/monode3/)
  Scran (v1.10.2)                                       [@R23]         <https://www.bioconductor.org/packages/release/bioc/html/scran.html>
  DICER                                                 [@R1]          <http://acgt.cs.tau.ac.il/dicer/>
  GOstats (v2.24.0)                                     [@R11]         <https://www.bioconductor.org/packages/release/bioc/html/GOstats.html>
  GSEAPY (v0.9.3)                                       N/A            <https://pypi.org/project/gseapy/>
  Bioconductor (v3.8)                                   N/A            <https://www.bioconductor.org/>
  GSEA (v2.2.2)                                         [@R32]         <https://software.broadinstitute.org/gsea/index.jsp>

###### Highlights

-   Systematic comparison to uncover unique features in each brain organoid protocol

-   Similar cell compositions across protocols

-   Distinct preference of differentiation trajectories across protocols

-   Generation of interneurons from human cortical organoids
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